Global Aptamers Market Insights, Size and Growth Forecast To 2030

COVID-19
Aptamers Market Size, Share & Trends Analysis By Product, By Applications, By Technology, By End Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Request COVID-19
impact analysis

Aptamers Market Size, Share & Trends Analysis By Product, By Applications, By Technology, By End Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Published: Mar 2022 Base Year: 2021 Report ID: BIOT2204
Available Format: Historical Data: 2019 - 2020 Number of Pages: 1 - 198
Category : Biotechnology
Global Aptamers Market is projected to be worth USD 592 million by 2030

According to SPER Market Research, the Aptamers Market estimated to reach USD 592 million by 2030 with a CAGR of 16.4%. Aptamers are short, single-stranded DNA, RNA, or synthetic XNA molecules, which bind to a specific target molecule. They are used to facilitate discoveries in basic research, ensure food safety and environment monitoring.

Increase in the occurrence of chronic diseases, the record breaking number of clinical trials, and awareness about the pros of aptamers than antibodies, growing investment in R&D, and aptamers-based therapeutics and diagnostics; are the fuel for the growth of aptamers market.

Impact of COVID-19 on the Aptamers Market
The outbreak of COVID-19 boosted the production companies which provide aptamers -based therapeutics & diagnostics.

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy product type, By Application, By Technology, By End Users, By Region
 Geographies covered North America, Europe, Asia Pacific, South America and Rest of the World
 Companies CoveredAptamer Group, Aptamer Sciences, Inc. Aptagen, LLC, Raptamer Discovery Group, SomaLogic Inc. 
Drivers: increasing awareness of pros of aptamers over antibodies
Aptamers can better target smaller molecules than antibody. Aptamers are used both in diagnostic & therapeutic applications. It can cross easily the BBB i.e. blood brain barrier, cost effective as compared to antibodies.

Restrains: Low market acceptance as compared to antibodies
Even though there is lots of a pro of aptamers than antibody, it has little affinity, less approval by the market, low acceptance by the scientific community. This is probable the reason for shrinkage of the market.

Opportunities: Growth in the venture capital funding for research on aptamers
Increase in the investment, increase venture capital, for both therapeutic and diagnostic applicable aptamers. This leads to the expansion of this market.
  


Challenges: Shortage of skilled & trained professionals
Need of trained person, highly technical, lack of personnel is the challenges to this market.

Global Aptamers Market, by Product:
Based upon product type, Aptamers market segmented as; DNA Aptamers, XNA Aptamers, RNA Aptamers.

Global Aptamers Market, by Application;
Based upon Application, Aptamers market segmented as; Therapeutics Development, Research & Development, Diagnostic, Others.

Global Aptamers Market, by Technology:
Based upon the Technology, Aptamers market segmented as; SELEX, Others.

Global Aptamers Market, by End Users:
Based upon the End Users, Aptamers market segmented as; Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs, Others

Global Aptamers Market, by End Region:
The biggest share of Aptamers Market is with North America. This is due to the existence of top market players, accessibility of funds for innovative techniques.

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Aptamers Market
4.4. Market Trends

5. Global Aptamers Market, by Product, 2019-2030 (USD Million)
5.1. DNA Aptamers
5.2. XNA Aptamers
5.3. RNA Aptamers

6. Global Aptamers Market, by Application, 2019-2030 (USD Million)
6.1. Therapeutics Development
6.2. Research & Development
6.3. Diagnostic
6.4. Others

7. Global Aptamers Market, by Technology, 2019-2030 (USD Million)
7.1. SELEX
7.2. Others

8. Global Aptamers Market, by End Users, 2019-2030 (USD Million)
8.1. Pharmaceutical & Biotechnology Companies
8.2. Academic & Government Research Institutes
8.3. CROs
8.4. Others
8.5. Global Aptamers Market, by End Users, 2019-2030 (USD Million)

9. Global Aptamers Market, by End Region, 2019-2030 (USD Million)
9.1. North America
9.2. Europe
9.3. APAC
9.4. Latin America
9.5. Middle East
9.6. Africa

10. Competitive Landscape
10.1. Introduction
10.2. Market Share Analysis, By Key Players 
10.3. Competitive Scenario 
10.3.1. Product Launches
10.3.2. Partnerships, Collaborations and Agreements
10.3.3. Acquisitions
10.3.4. Expansions
10.3.5. Other Developments

11. Company Profiles
11.1. Aptagen, LLC 
11.2. Aptamer Group
11.3. Aptamer Sciences, Inc. 
11.4. Raptamer Discovery Group
11.5. SomaLogic Inc.

12. Appendix


SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Global Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 4250
  • 20% off
             
    $ 5650
  • 25% off
         
    $ 7450
Pre-Purchase Enquiry
SEND AN ENQUIRY
NEED CUSTOMIZATION?
Request Customization
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us